Study shows AI can deliver specialty-level diagnosis in primary care setting

(University of Iowa Health Care) A system designed by a University of Iowa ophthalmologist that uses artificial intelligence (AI) to detect diabetic retinopathy without a person interpreting the results earned Food and Drug Administration (FDA) authorization in April, following a clinical trial in primary care offices. The study was the first to prospectively assess the safety of an autonomous AI system in patient care settings. The results, published in Nature Digital Medicine, show the data that led to FDA clearance.